People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Biotechnology, Other Technology, Retailing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. | — | Biotechnology | Series D+ | $181.8M | $1.6B | 2024 |
| Clarus Parent Holdings, Llc | — | Other Technology | Series C | $64.6M | $2.0B | 2016 |
| Second Rotation Inc | — | Retailing | Series B | $43.2M | $53.6M | 2011 |
Christopher Sullivan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher Sullivan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Miller | 1 | 29 |
| Isaac Blech | 1 | 14 |
| Michael Tyrrell | 1 | 8 |
| EUGENE A. BAUER | 1 | 7 |
| Sol J. Barer | 1 | 6 |
| Andrew Williamson | 1 | 6 |
| Aaron Kantoff | 1 | 6 |
| William Rosenzweig | 1 | 5 |
| Henry Vogel | 1 | 4 |
| Phil Gutry | 1 | 4 |
| Magnus Persson | 1 | 3 |
| Frank A. Torti | 1 | 3 |
| Eugene Bauer | 1 | 3 |
| Behshad Sheldon | 1 | 3 |
| TOM CAPORASO | 1 | 3 |
| ULI HACKSELL | 1 | 3 |
| Alexander Ellis III | 1 | 3 |
| Isaac A. Blech | 1 | 3 |
| Isaac M. Blech | 1 | 2 |
| Ashton Peery | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.